… are here to support your developments of mAbs , ADCs and proteins. 12 years’ experience with CBMPs: Cell-Based … regulatory landscape, the physicochemical and biological characterisation of viral vector-based products is …
… from various horizons, as Antibody-Drug Conjugates (ADCs) bring together people with many skills and various … physicians and policy makers to exchange about therapeutic ADCs. Mr David Wyngaert, Business Development Director & Dr …